Eiger BioPharmaceuticals, Inc.
TREATMENT OF HEPATITIS DELTA VIRUS INFECTION WITH INTERFERON LAMBDA
Last updated:
Abstract:
Methods of treating a hepatitis delta virus (HDV) infection in a human subject are provided. In some embodiments, the method comprises subcutaneously administering to the subject a therapeutically effective amount of pegylated interferon lambda-1a for at least 48 weeks.
Status:
Application
Type:
Utility
Filling date:
23 Aug 2019
Issue date:
24 Jun 2021